How much revenue does Instadose Pharma make?

Instadose Pharma reported $0 in revenue for fiscal year 2021. In Q1 2022 revenue was $0.

What companies are similar to Instadose Pharma?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Biome Grow Inc. (BIOIF), Mera Pharmaceuticals, Inc. (MRPI), Hero Technologies Inc. (HENC), BellRock Brands Inc. (DXBRF).

Instadose Pharma Corp. (INSD) Stock

About Instadose Pharma Corp.

Instadose Pharma Corp. engages in growing, cultivation, processing, and global distribution of medical-grade cannabinoid oil. The company was founded in 2017 and is based in Burlington, Canada.

At a glance

Instadose Pharma reported revenue of $0 for fiscal year 2021, and net income of -$588,714. In Q1 2022 (the quarter ended February 28, 2022) revenue was $0.

Figures from company filings; latest fiscal year ended November 30, 2021.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.